Company: FVN
Filing Date: 2025-05-02
Form Type: S-4
Source: 0001829126-25-003304
Chunk: 158

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-05-02
Form: S-4
Chunk 158
---
 industry analysts do not currently, and may never, publish research on New VIWO. If no securities or industry analysts commence coverage of New VIWO, the trading price for its ordinary shares would likely be negatively impacted. In the event securities or industry analysts initiate coverage, if one or more of the analysts who cover New VIWO downgrade its securities or publish inaccurate or unfavorable research about its business, its stock price would likely decline. If one or more of these analysts cease coverage of New VIWO or fail to publish reports on New VIWO, demand for its ordinary shares could decrease, which might cause its ordinary share price and trading volume to decline.

If New VIWO cannot satisfy, or continue to satisfy, the initial listing requirements and other rules of Nasdaq, New VIWO’s securities may not be listed or may be delisted, which could negatively impact the price of its securities and your ability to sell them.

New VIWO will seek to have its securities approved for listing on the Nasdaq Capital Market. New VIWO cannot assure you that it will be able to meet the initial listing requirement including shareholders’ equity, minimum share price, minimum market value of publicly held shares, 300 round lot shareholders and various additional requirements in order to obtain approval to list on the Nasdaq Capital Market. Even if New VIWO’s securities are listed on Nasdaq, it cannot assure you that its securities will continue to be listed on Nasdaq.

In addition, in order to maintain its listing on Nasdaq, New VIWO will be required to comply with certain rules of Nasdaq, including those regarding minimum shareholders’ equity, minimum share price, minimum market value of publicly held shares, 300 round lot shareholders and various additional requirements. Even if New VIWO initially meets the listing requirements and other applicable rules of Nasdaq, New VIWO may not be able to continue to satisfy these requirements and applicable rules. If New VIWO is unable to satisfy Nasdaq criteria for maintaining its listing, its securities could be subject to delisting.

If Nasdaq does not list New VIWO’s securities, or subsequently delists its securities from trading, New VIWO could face significant consequences, including:

| ● | a limited availability for market quotations for its securities;                                                                                                                                                                                                                           |
| ● | reduced liquidity with respect to New VIWO’s securities;                                                                                                                                                                                                                                   |
| ● | a determination that its ordinary shares is a “penny stock,” which will require brokers trading in New VIWO’s ordinary shares to adhere to more stringent rules and possibly result in a reduced